Bioresorbable vascular scaffold use in a case of in-stent restenosis

Arquivos Brasileiros de Cardiologia

Volumn 103, Issue 1, 2014, Pages

  Cadrin Tourigny, Julia ^a   Dong, Liang ^b   Maehara, Akiko ^b   Schampaert, Erick ^a   Genereux, Philippe ^a,b  

^a HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^b NewYork Presbyterian Hospital   (United States)

Author keywords

Bioresorbable vascular scaffold; Cardiac catheterization; Coronary artery disease; Stents

Indexed keywords

ACETYLSALICYLIC ACID; EVEROLIMUS; TICAGRELOR; IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN;

AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; BIORESORBABLE VASCULAR STENT; CASE REPORT; CORONARY ARTERY ANEURYSM; DRUG ELUTING STENT; FOLLOW UP; HUMAN; HYPERSENSITIVITY; IN-STENT RESTENOSIS; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MICROANEURYSM; NOTE; OPTICAL COHERENCE TOMOGRAPHY; PERCUTANEOUS CORONARY INTERVENTION; STAPLER; THROMBUS; THROMBUS ASPIRATION; ANALOGS AND DERIVATIVES; CORONARY RESTENOSIS; DEVICES; PROCEDURES; RADIOGRAPHY;

AGED; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; PERCUTANEOUS CORONARY INTERVENTION; SIROLIMUS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84906070159     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.5935/abc.20140098     Document Type: Note

References (4)

1. Ormiston JA, Serruys PW, Regar E, Dudek D, Thuesen L, Webster MW, et al. A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a p rospective open-labeltrial. Lancet. 2008;371(9616):899-907.
2. Serruys PW, Onuma Y, Ormiston JA, de Bruyne B, Regar E, Dudek D, et al. Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes. Circulation. 2010;122(22):2301-12.
3. Serruys PW, Ormiston JA, Onuma Y, Regar E, Gonzalo N, Garcia-Garcia HM et al. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet. 2009;373(9667):897-910.
4. Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation.2004;109(6):701-5.